Stress Reduction and Hypertension Prevention in African Americans
NCT ID: NCT04821505
Last Updated: 2021-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
304 participants
INTERVENTIONAL
1998-05-01
2005-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants (n=304) were randomized to either the Transcendental Meditation technique or Health Education control in addition to usual care for up to 36 months for BP and secondary outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Controlled Trial of Stress Reduction on Cardiovascular Morbidity and Mortality in African Americans
NCT01299935
Brief Trainings to Buffer Against Acute Stress Effects
NCT02214264
The Effects of Mindfulness Training on Pain Regulation, Negative Affect, Attention, and Social Stress
NCT01301105
Stress Reduction Training for Emotion Regulation and Well-Being
NCT03485807
Impact of Mindfulness Training on Stress-related Health Outcomes in Law Enforcement
NCT03488875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: This randomized controlled trial was conducted to evaluate the effect of stress reduction with the Transcendental Meditation (TM) technique in Black adults with high normal BP and normal BP using International Society of Hypertension (ISH) definitions.
Methods: A total of 304 Black adults with high normal (130-139/85-89 mm Hg) and normal BP (120-129/80-84 mm Hg) were randomized to either TM or health education (HE) arms. BP was recorded at 3, 6, 9, 12, 24, 30, and 36 months after baseline. Linear mixed model analysis was conducted to compare the BP change between TM and HE participants in the high-normal BP and normal-BP groups. Survival analysis for hypertensive events was conducted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meditation
The Transcendental Meditation program is described as a simple natural technique practiced for 20 minutes twice daily for deep rest and relaxation. Previous studies have shown its feasibility, validity, and reliability in Blacks at risk for CVD.
Transcendental Meditation
TM is described as simple technique practiced 20 minutes twice a day for deep rest and relaxation.
Health Education
Health education program matched to the experimental intervention for time, attention, and other non-specific factors.
Health Education
didactic classroom instruction on improving ones lifestyle through healthier diet, exercise and control of substance use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health Education
didactic classroom instruction on improving ones lifestyle through healthier diet, exercise and control of substance use.
Transcendental Meditation
TM is described as simple technique practiced 20 minutes twice a day for deep rest and relaxation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no current antihypertensive medications
* high normal BP (130-139 mm Hg and/or DBP 85-89 mm Hg) OR
* normal BP (SBP 120-129 mm Hg and/DBP 80-84 mm Hg)
Exclusion Criteria
* history of CVD, ie, myocardial infarction, angina, peripheral artery disease, heart failure, stroke, or renal failure, diabetes, major psychiatric or substance use disorder other life-threatening illness
* lack of signed a consent form
21 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical College of Wisconsin
OTHER
Maharishi International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Schneider, MD
Director and Dean
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert H Schneider, M.D.
Role: PRINCIPAL_INVESTIGATOR
Maharishi International University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HL60703-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.